Switch to: References

Add citations

You must login to add citations.
  1. Public Engagement through Inclusive Deliberation: The Human Genome International Commission and Citizens’ Juries.Naomi Scheinerman - 2022 - American Journal of Bioethics 23 (12):66-76.
    In this paper, I take seriously calls for public engagement in human genome editing decision-making by endorsing the convening of a “Citizens Jury” in conjunction with the International Commission on the Clinical Use of Human Germline Genome Editing’s next summit scheduled for March 6–8, 2023. This institutional modification promises a more inclusive, deliberative, and impactful form of engagement than standard bioethics engagement opportunities, such as comment periods, by serving both normative and political purposes in the quest to offer moral guidance (...)
    Download  
     
    Export citation  
     
    Bookmark   9 citations  
  • Response to Open Peer Commentaries on “Public Engagement through Inclusive Deliberation: The Human Genome International Commission and Citizens’ Juries”.Naomi Scheinerman - 2022 - American Journal of Bioethics 23 (12):1-3.
    I greatly appreciate the open peer commentary authors’ thoughtful engagement with my proposal to include a Citizens’ Jury (CJ) at the level of the International Commission when exploring ethical re...
    Download  
     
    Export citation  
     
    Bookmark  
  • Researching the future: scenarios to explore the future of human genome editing.Cynthia Selin, Lauren Lambert, Stephanie Morain, John P. Nelson, Dorit Barlevy, Mahmud Farooque, Haley Manley & Christopher T. Scott - 2023 - BMC Medical Ethics 24 (1):1-12.
    Background Forward-looking, democratically oriented governance is needed to ensure that human genome editing serves rather than undercuts public values. Scientific, policy, and ethics communities have recognized this necessity but have demonstrated limited understanding of how to fulfill it. The field of bioethics has long attempted to grapple with the unintended consequences of emerging technologies, but too often such foresight has lacked adequate scientific grounding, overemphasized regulation to the exclusion of examining underlying values, and failed to adequately engage the public. Methods (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Technical Categories and Ethical Justifications: Why Cwik’s Approach is the Wrong Way Around for Categorizing Germ-Line Gene Editing.Anthony Wrigley & Ainsley J. Newson - 2020 - American Journal of Bioethics 20 (8):27-29.
    Volume 20, Issue 8, August 2020, Page 27-29.
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Enriching, Rather than Revising, the Conceptual Toolbox on Germline Interventions.Alexandre Erler - 2020 - American Journal of Bioethics 20 (8):25-27.
    Volume 20, Issue 8, August 2020, Page 25-27.
    Download  
     
    Export citation  
     
    Bookmark  
  • What Counts as “Success” in Speculative and Anticipatory Ethics? Lessons from the Advent of Germline Gene Editing.Ari Schick - 2019 - NanoEthics 13 (3):261-267.
    This discussion note offers a preliminary analysis of what recent developments in human germline gene editing tell us about the effectiveness of speculative and anticipatory modes of techno-ethics. It argues that the benefits of speculative discussions are difficult to detect thus far, and that pushing the focal point of ethical discourse well ahead of the current state of technology may prematurely undermine existing norms long before a broad consensus would justify moving beyond them.
    Download  
     
    Export citation  
     
    Bookmark   5 citations  
  • The ‘serious’ factor in germline modification.Erika Kleiderman, Vardit Ravitsky & Bartha Maria Knoppers - 2019 - Journal of Medical Ethics 45 (8):508-513.
    Current advances in assisted reproductive technologies aim to promote the health and well-being of future children. They offer the possibility to select embryos with the greatest potential of being born healthy (eg, preimplantation genetic testing) and may someday correct faulty genes responsible for heritable diseases in the embryo (eg, human germline genome modification (HGGM)). Most laws and policy statements surrounding HGGM refer to the notion of ‘serious’ as a core criterion in determining what genetic diseases should be targeted by these (...)
    Download  
     
    Export citation  
     
    Bookmark   9 citations  
  • What to Expect When Expecting CRISPR Baby Number Four.Cynthia Selin & Christopher Thomas Scott - 2019 - American Journal of Bioethics 19 (3):7-9.
    Download  
     
    Export citation  
     
    Bookmark   7 citations